Toxicity Attribution in Phase I Trials: Evaluating the Effect of Dose on the Frequency of Related and Unrelated Toxicities

BACKGROUND: Phase I studies rely on investigators to accurately attribute of adverse events as related or unrelated to study drug. This information is ultimately used to help establish a safe dose. Patterns of physician attribution in the Phase I setting have not been widely studied and assessing th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Cancer Res
Main Authors: Eaton, Anne, Iasonos, Alexia, Gounder, Mrinal M, Pamer, Erika G, Drilon, Alexander, Vulih, Diana, Smith, Gary L, Percy Ivy, S., Spriggs, David R, Hyman, David M
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4819316/
https://ncbi.nlm.nih.gov/pubmed/26324741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-0339
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki